微载体规模化培养MDCK细胞增殖H9N2亚型禽流感病毒的研究

Research on multiplication of the H9N2 subtype avian influenza virus in large-scale microcarrier-based MDCK cell culture system

目的探索H9N2亚型禽流感病毒株(A/Chiken/NX/9/99)在微载体大规模培养的MDCK细胞中的增殖规律,确定最佳增殖条件。方法将H9N2亚型禽流感病毒株接种到生长在24孔培养板上的MDCK细胞中进行增殖试验,检测接种不同感染剂量病毒、添加不同浓度TPCK-胰酶、在不同pH值的培养液中培养,接毒后不同时间的病毒血凝素滴度(HA)。根据最佳增殖条件将病毒接种至生长在微载体上的MDCK细胞中,利用250 mL和5L转瓶逐级进行大规模增殖。结果最佳病毒增殖条件为TPCK-胰酶终浓度为10μg/mL,接毒剂量为MOI=0.025,培养液pH值为7.4,在此条件下,H9N2亚型禽流感病毒株(A/Chiken/NX/9/99)适应在250 mL和5L转瓶中微载体培养的MDCK细胞内大量增殖,病毒的最高血凝价均可达到9log2(1∶512)。结论本研究为以哺乳动物细胞为基质规模化生产禽流感疫苗奠定了基础。

To explore the regularity for the multiplication of avian influenza virus subtype H9N2 in large-scale microcarrier-based MDCK cell culture system, and to determine the optimal proliferation conditions. H9N2 subtype of avian influenza virus was inoculated into the MDCK cell growing on 24 well plate, and the HA titers of virus at different time were detected in the conditions of different infectious doses,different concentrations of TPCK trypsin and different pH. The optimal conditions were determined. Then the H9N2 subtype avian influenza virus was grown in microcarrier-based MDCK cell in 250mL and 5L roller bottles. It was demonstrated that high viruse yield with a hemagglutination unit of 9 log2（1 ： 512） could be obtained under the optimal conditions of multiplication . The result indicated the H9N2 subtype avian influenza virus could be produced in microcarrier-based MDCK cell in a large-scale culture system with a high virus yield and demonstrates the feasibility of the development of mammalian cell-based in influenza vaccine in microcarrier culture systems.